Codiak BioSciences, Inc. announced the promotion of Sriram Sathyanarayanan, Ph.D., who has led Codiak’s preclinical research efforts for the past four years to Chief Scientific Officer. Additionally, Konstantin Konstantinov, Ph.D., who has spearheaded the company’s manufacturing and process sciences since Codiak’s inception, has been named Chief Technology Officer. Prior to this appointment, Dr. Sathyanarayanan was Senior Vice President, Preclinical Development. In this role, he designed and led the preclinical evaluation of all of Codiak’s development programs in oncology/immuno-oncology, including exoIL-12 and exoSTING, which are currently in Phase 1/2 clinical trials, and exoASO-STAT6, for which Codiak expects to file an Investigational New Drug application this year. Dr. Konstantinov most recently held the position of Executive Vice President, Manufacturing and Process Sciences.